Femasys Inc
FEMY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001339005
In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.
Holders of 5% or more of FEMY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Femasys Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Alumni Capital LP | 13G | 9.99%4.77M shares | New | Sep 4, 20251 filing | Sep 4, 2025 | SEC |
| Dauntless Investment Group, LLC | 13G/A | 9.90%4.40M shares | +4.50 ppfrom 5.40% | Feb 26, 20252 filings | Nov 14, 2025 | SEC |
| Chernett Jorey | 13G/A | 9.30%3.03M shares | +3.10 ppfrom 6.20% | Feb 26, 20252 filings | Aug 5, 2025 | SEC |
| PharmaCyte Biotech, Inc. | 13G | 7.87%4.93M shares | New | Mar 18, 20261 filing | Mar 18, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Femasys Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 20265:00 PM ET | PharmaCyte Biotech, Inc. | 13G | 7.87%4.93M shares | New | Mar 17, 2026 | SEC |
| Nov 14, 202512:46 PM ET | Dauntless Investment Group, LLC | 13G/A | 9.90%4.40M shares | +4.50 ppfrom 5.40% | Sep 30, 2025 | SEC |
| Sep 4, 20259:35 PM ET | Alumni Capital LPand 2 others | 13G | 9.99%4.77M shares | New | Sep 4, 2025 | SEC |
| Aug 5, 20253:28 PM ET | Chernett Jorey | 13G/A | 9.30%3.03M shares | +3.10 ppfrom 6.20% | Jun 30, 2025 | SEC |
| Feb 26, 20258:10 PM ET | Chernett Jorey | 13G | 6.20%1.62M shares | New | Feb 19, 2025 | SEC |
| Feb 26, 20251:46 PM ET | Dauntless Investment Group, LLC | 13G | 5.40%1.43M shares | New | Feb 18, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Femasys Inc shares.
No Form 144 notices for Femasys Inc are on file.